Search Results 1621-1630 of 21405 for anti-TNF drugs

1. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   Herbal medications with unknown properties or known beneficial effects for AD. Within 1 week of first dose of investigational product: Anti-platelet drugs.

2. Fluticasone (Nasal Route) Precautions - Mayo Clinic

   If you think your child is not growing properly while using this medicine, talk with your doctor. Do not take other medicines unless they have been discussed ...

3. Progestin (Oral Route, Parenteral Route, Vaginal Route) Description and Brand Names - Mayo Clinic

   OHT is also called hormone replacement therapy (HRT) and estrogen replacement therapy (ERT). To treat pain that is related to endometriosis, a condition where ...

4. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... treatment with more than 1 oral PAH-approved therapy or any parenteral therapy. ... anti-fibrotic drug within 4 ...

5. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

   Participants taking anti-diabetic, anti-obesity, or anti-dyslipidemic medications must have been on stable regimens for at least 3 months (12 weeks) (6 ...

6. Ripretinib (Oral Route) Description and Brand Names - Mayo Clinic

   Ripretinib is used to treat gastrointestinal stromal tumor (GIST) in patients who have received treatment with at least 3 other medicines (eg, imatinib).

7. Blood and Marrow Transplant Research Program - Transplant Research Center - Mayo Clinic Research

   Develop novel treatment approaches of GVHD; Test established and state-of-the-art GVHD treatment regimens, such as anti-thymocyte globulin (ATG), post ...

8. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   By condition, treatment or drug ... anti-PD1, anti-PDL1 or anti-CTLA4 antibodies. ... Patients under chronic treatment with systemic corticosteroids or other ...

9. A Study to Evaluate Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers - Mayo Clinic

   - For Cohorts 2A and 2B: prior anti-HER2 therapies - For Cohorts 1E, 1F, 1G, 2A: Prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an ...

10. Immune Globulin (Intramuscular Route, Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Immune globulin injection belongs to a group of medicines known as immunizing agents. ... Drugs & Supplements; Immune Globulin (Intramuscular Route, Intravenous ...